Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Scheffer

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Current Atherosclerosis Reports|September 26, 2014
8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic reviewLona J Kroese, Peter G Scheffer
Current Opinion in Hematology|September 20, 2011
The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasmaPeter G Scheffer, Masja de Haas, C Ellen van der Schoot
Journal of Lipid Research|February 18, 2004
Combined data from LDL composition and size measurement are compatible with a discoid particle shapeTom Teerlink, Peter G Scheffer, Stephan J L Bakker, et al.
Psychoneuroendocrinology|March 21, 2017
The association between three major physiological stress systems and oxidative DNA and lipid damageCatherine N Black, Mariska Bot, Dóra Révész, et al.
Clinical Chemistry|June 27, 2009
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?Roger K Schindhelm, Leonard P van der Zwan, Tom Teerlink, et al.
Oxidative Medicine and Cellular Longevity|March 24, 2016
Sociodemographic and Lifestyle Determinants of Plasma Oxidative Stress Markers 8-OHdG and F2-Isoprostanes and Associations with Metabolic SyndromeCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart diseaseHelene von Bibra, Michaela Diamant, Peter G Scheffer, et al.
Psychoneuroendocrinology|December 3, 2014
Is depression associated with increased oxidative stress? A systematic review and meta-analysisCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Bioethics|November 11, 2024
Autonomy and prevention: From conflicting to complementary aims of prenatal screeningWybo Dondorp, Guido de Wert, Ellis C Becking, et al.
Journal of Affective Disorders|September 17, 2017
Uric acid in major depressive and anxiety disordersCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Atherosclerosis Reports|September 26, 2014
8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic reviewLona J Kroese, Peter G Scheffer
Current Opinion in Hematology|September 20, 2011
The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasmaPeter G Scheffer, Masja de Haas, C Ellen van der Schoot
Journal of Lipid Research|February 18, 2004
Combined data from LDL composition and size measurement are compatible with a discoid particle shapeTom Teerlink, Peter G Scheffer, Stephan J L Bakker, et al.
Psychoneuroendocrinology|March 21, 2017
The association between three major physiological stress systems and oxidative DNA and lipid damageCatherine N Black, Mariska Bot, Dóra Révész, et al.
Clinical Chemistry|June 27, 2009
Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?Roger K Schindhelm, Leonard P van der Zwan, Tom Teerlink, et al.
Oxidative Medicine and Cellular Longevity|March 24, 2016
Sociodemographic and Lifestyle Determinants of Plasma Oxidative Stress Markers 8-OHdG and F2-Isoprostanes and Associations with Metabolic SyndromeCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Diabetes & Vascular Disease Research|October 30, 2008
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart diseaseHelene von Bibra, Michaela Diamant, Peter G Scheffer, et al.
Psychoneuroendocrinology|December 3, 2014
Is depression associated with increased oxidative stress? A systematic review and meta-analysisCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Bioethics|November 11, 2024
Autonomy and prevention: From conflicting to complementary aims of prenatal screeningWybo Dondorp, Guido de Wert, Ellis C Becking, et al.
Journal of Affective Disorders|September 17, 2017
Uric acid in major depressive and anxiety disordersCatherine N Black, Mariska Bot, Peter G Scheffer, et al.
Pageof 6